Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 1
2017 2
2018 3
2019 1
2021 5
2022 7
2023 9
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W, Coupland CAC, Burchardt J, Baldwin DR; DART initiative; Gleeson FV, Hippisley-Cox J. Liao W, et al. Lancet Respir Med. 2023 Aug;11(8):685-697. doi: 10.1016/S2213-2600(23)00050-4. Epub 2023 Apr 5. Lancet Respir Med. 2023. PMID: 37030308 Free article.
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine.
Vellekoop H, Huygens S, Versteegh M, Szilberhorn L, Zelei T, Nagy B, Koleva-Kolarova R, Tsiachristas A, Wordsworth S, Rutten-van Mölken M; HEcoPerMed Consortium. Vellekoop H, et al. Among authors: koleva kolarova r. Pharmacoeconomics. 2021 Jul;39(7):771-788. doi: 10.1007/s40273-021-01010-z. Epub 2021 Apr 16. Pharmacoeconomics. 2021. PMID: 33860928 Free PMC article.
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis.
Vellekoop H, Versteegh M, Huygens S, Corro Ramos I, Szilberhorn L, Zelei T, Nagy B, Tsiachristas A, Koleva-Kolarova R, Wordsworth S, Rutten-van Mölken M; HEcoPerMed consortium. Vellekoop H, et al. Among authors: koleva kolarova r. Value Health. 2022 Aug;25(8):1428-1438. doi: 10.1016/j.jval.2022.01.006. Epub 2022 Mar 2. Value Health. 2022. PMID: 35248467 Free article. Review.
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.
Koleva-Kolarova R, Buchanan J, Vellekoop H, Huygens S, Versteegh M, Mölken MR, Szilberhorn L, Zelei T, Nagy B, Wordsworth S, Tsiachristas A; HEcoPerMed Consortium. Koleva-Kolarova R, et al. Appl Health Econ Health Policy. 2022 Jul;20(4):501-524. doi: 10.1007/s40258-021-00714-9. Epub 2022 Apr 4. Appl Health Econ Health Policy. 2022. PMID: 35368231 Free PMC article.
28 results